Chemoinformaics analysis of Dihydrostilbene Dihydroxyresveratrol
| Molecular Weight | 442.511 | nRot | 4 |
| Heavy Atom Molecular Weight | 416.303 | nRig | 13 |
| Exact Molecular Weight | 442.178 | nRing | 4 |
| Solubility: LogS | -2.978 | nHRing | 0 |
| Solubility: LogP | 1.173 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 3 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 18 |
| nHA | 5 | APOL | 68.1066 |
| nHD | 5 | BPOL | 26.0834 |
| QED | 0.63 |
| Synth | 2.716 |
| Natural Product Likeliness | 0.542 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.02 |
| Pgp-sub | 0.051 |
| HIA | 0.032 |
| CACO-2 | -5.079 |
| MDCK | 0.00000565 |
| BBB | 0.073 |
| PPB | 0.758664 |
| VDSS | 0.456 |
| FU | 0.220851 |
| CYP1A2-inh | 0.506 |
| CYP1A2-sub | 0.076 |
| CYP2c19-inh | 0.108 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.27 |
| CYP2c9-sub | 0.93 |
| CYP2d6-inh | 0.471 |
| CYP2d6-sub | 0.547 |
| CYP3a4-inh | 0.877 |
| CYP3a4-sub | 0.145 |
| CL | 5.89 |
| T12 | 0.825 |
| hERG | 0.064 |
| Ames | 0.066 |
| ROA | 0.115 |
| SkinSen | 0.873 |
| Carcinogencity | 0.023 |
| EI | 0.696 |
| Respiratory | 0.064 |
| NR-Aromatase | 0.055 |
| Antiviral | Yes |
| Prediction | 0.681953 |